Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

As new coronavirus outbreaks emerge, fears of a global pandemic escalate

Increased quarantine measures are reported across the globe

- PMLiVE

Lilly’s Trulicity scores CV reduction indication in the US

Approved for risk reduction in primary and secondary populations

- PMLiVE

BMS scores first oesophageal cancer nod for Opdivo in Japan

Approval in Japan comes before US okay

- PMLiVE

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Big comeback after previous trial fail

- PMLiVE

Lundbeck gets US approval for migraine drug at heart of Alder takeover

US regulator clears CGRP inhibitor under Vyepti trade name

- PMLiVE

BRIC markets

Why these countries offer an opportunity for pharma despite a slowdown

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story

Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.

Impetus Digital

Courageous Conversations ep.4: Five Key Benefits of the Internet of Medical Things

Impetus Digital

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Impetus Digital

- PMLiVE

Bedrock Group celebrates a trio of new hires

Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.

Bedrock Healthcare Communications

- PMLiVE

Researchers discover new antibiotic using AI

First antibiotic to be discovered using this method

- PMLiVE

Tocagen merges with Forte Biosciences after brain cancer fail

New company will focus on Forte's lead skin disease drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links